🇺🇸 FDA

Intelligence · Clinical Pipeline

Takeda Pipeline

All ClinicalTrials.gov programs at Takeda — phase, modality, and trial IDs.

Programs
154

Quick answer

Takeda has 154 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. "Nycoplus Magnesium" (120 mg x 3 daily for 2 weeks)

    Takeda

    Cramps

    approved small molecule completed

    1 trial

  2. 1 TachoSil hemostatic sponge (9,5 cm x 4,8 cm) placed on each side on the external iliac artery.

    Takeda

    Prostate or Bladder Cancer

    approved small molecule completed

    1 trial

  3. 1-84 parathyroid hormone

    Takeda

    Shoulder Fractures

    approved small molecule active

    1 trial

  4. AD-4833 15 mg

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    1 trial

  5. ADVATE

    Takeda

    Hemophilia A

    approved mab completed

    1 trial

  6. AO-128

    Takeda

    Impaired Glucose Tolerance (IGT)

    approved small molecule completed

    1 trial

  7. ARALAST Alpha1-Proteinase Inhibitor

    Takeda

    Alpha1-antitrypsin Deficiency

    approved small molecule terminated

    1 trial

  8. ARALAST NP

    Takeda

    Chronic Obstructive Pulmonary Disease

    approved mab terminated

    1 trial

  9. Adalimumab

    Takeda

    Crohn's Disease

    approved small molecule active

    1 trial

  10. Alofisel 5 × 106 cells/mL dispersion for injection.

    Takeda

    Perianal fistulising Crohn´s disease

    approved small molecule active

    1 trial

  11. Alogliptin

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule completed

    6 trials

  12. Alpha1-Proteinase Inhibitor

    Takeda

    Alpha 1-Antitrypsin Deficiency

    approved mab completed

    1 trial

  13. Alpha1-proteinase inhibitor

    Takeda

    Alpha1-antitrypsin Deficiency

    approved mab completed

    1 trial

  14. Ampicillin

    Takeda

    Surgical Site Infection

    approved small molecule completed

    1 trial

  15. Anagrelide

    Takeda

    Thrombocythemia, Hemorrhagic

    approved small molecule completed

    1 trial

  16. Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method

    Takeda

    Hemophilia A

    approved mab completed

    4 trials

  17. Antihemophilic factor, recombinant, manufactured protein-free

    Takeda

    Hemophilia A

    approved small molecule completed

    6 trials

  18. Azilsartan

    Takeda

    Essential Hypertension With Stable Angina and Dyslipidemia

    approved small molecule terminated

    1 trial

  19. Azilsartan

    Takeda

    Essential Hypertension Complicated by Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  20. Azilsartan Medoxomil

    Takeda

    Essential Hypertension

    approved small molecule completed

    2 trials

  21. BLB-750 Vaccine (Qinghai RG strain)

    Takeda

    Pandemic Influenza Prevention

    approved mab completed

    1 trial

  22. Brentuximab vedotin

    Takeda

    Lymphoma

    approved small molecule active

    2 trials

  23. Brentuximab vedotin

    Takeda

    T-Cell Lymphoma

    approved small molecule completed

    1 trial

  24. C1 inhibitor (human) [C1 INH]

    Takeda

    Hereditary Angioedema

    approved mab completed

    1 trial

  25. CDPATH™

    Takeda

    Crohn's Disease

    approved other active

    1 trial

  26. Caffeine

    Takeda

    Colitis, Ulcerative

    approved small molecule terminated

    1 trial

  27. Calcichew D3

    Takeda

    Calcium and Vitamin D Deficiencies

    approved small molecule completed

    1 trial

  28. Candesartan

    Takeda

    Cerebrovascular Accident

    approved small molecule active

    1 trial

  29. Candesartan and Hydrochlorothiazide

    Takeda

    Obesity

    approved small molecule completed

    1 trial

  30. Candesartan cilexetil and hydrochlorothiazide

    Takeda

    Hypertension

    approved small molecule completed

    1 trial

  31. Cardiovascular drugs strategies

    Takeda

    High Risk Hypertensive Patients

    approved other completed

    1 trial

  32. Ciclesonide

    Takeda

    Allergic Rhinitis

    approved small molecule completed

    1 trial

  33. Colchicine

    Takeda

    Pharmacokinetics

    approved small molecule completed

    1 trial

  34. Colchicine

    Takeda

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  35. Coumarin/troxerutin

    Takeda

    Chronic Venous Insufficiency

    approved small molecule completed

    1 trial

  36. Darvadstrocel

    Takeda

    Crohn's Disease

    approved mab terminated

    3 trials

  37. Dexlansoprazole

    Takeda

    Gastroesophageal Reflux Disease

    approved small molecule completed

    4 trials

  38. Dexlansoprazole 60 MG

    Takeda

    GERD

    approved small molecule completed

    1 trial

  39. Digital Engagement Application (GD App)

    Takeda

    Gaucher Disease

    approved other completed

    1 trial

  40. Double dose of PPI

    Takeda

    Dyspepsia

    approved small molecule completed

    1 trial

  41. Dynepo

    Takeda

    Anemia

    approved small molecule terminated

    1 trial

  42. ELAPRASE

    Takeda

    Mucopolysaccharidosis (MPS)

    approved small molecule terminated

    1 trial

  43. Elaprase

    Takeda

    Hunter Syndrome

    approved mab completed

    1 trial

  44. Elaprase for intravenous (IV) infusion

    Takeda

    Hunter Syndrome

    approved small molecule completed

    1 trial

  45. Factor IX Concentrate (purified, virus-inactivated)

    Takeda

    Hemophilia B

    approved mab completed

    1 trial

  46. Febuxostat

    Takeda

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  47. Febuxostat

    Takeda

    Gout

    approved small molecule completed

    6 trials

  48. Feiba

    Takeda

    Hemophilia A With Inhibitor

    approved small molecule active

    1 trial

Frequently asked questions

How many pipeline programs does Takeda have?

154 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.